Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Mental Health

Long-term and preventative treatment for seasonal affective disorder

Three large, randomised, placebo-controlled studies have shown that preventative treatment with bupropion XL reduces the recurrence rate of depressive episodes in patients with SAD.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This review examines long-term and preventative treatments for seasonal affective disorder, a recurrent winter depression. The authors report that light therapy usually needs daily continuation through winter because relapse is rapid when it stops early, and that bupropion XL reduced depressive recurrence in three large placebo-controlled studies. They note few studies of longer or preventative treatment, so the evidence base is limited.

Who or what was studied
Patients with seasonal affective disorder (SAD)
Limits stated in the abstract
The abstract states that few studies of longer-term and preventative treatment exist and that light therapy studies have methodological limitations.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Bright light therapy, Placebo-controlled. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Mental Health

[Pharmacotherapy of seasonal depression]

So far, selective serotonin reuptake inhibitors and possibly compounds with a distinct noradrenergic mechanism of action seem to be the treatment of choice for seasonal depression.

Review · January 1, 2002 · Hilger E et al.